Christophe Bergeron
National Institutes of Health(US)Institute on Aging(US)National Institute on Aging(US)
Publications by Year
Research Areas
Renal and related cancers, Neuroblastoma Research and Treatments, Sarcoma Diagnosis and Treatment, Renal cell carcinoma treatment, Childhood Cancer Survivors' Quality of Life
Most-Cited Works
- → Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing(2011)540 cited
- → Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP–RTSG 2016 protocol(2017)366 cited
- → Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial(2019)232 cited
- → Frequent hSNF5/INI1 Germline Mutations in Patients with Rhabdoid Tumor(2011)221 cited
- → Omission of doxorubicin from the treatment of stage II–III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial(2015)204 cited
- → Randomized Comparison of Intensified Six-Drug Versus Standard Three-Drug Chemotherapy for High-Risk Nonmetastatic Rhabdomyosarcoma and Other Chemotherapy-Sensitive Childhood Soft Tissue Sarcomas: Long-Term Results From the International Society of Pediatric Oncology MMT95 Study